Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$279K Sell
3,297
-517
-14% -$41.7K 0.03% 368
2026
Q1
$270K Sell
3,814
-197
-5% -$14.7K 0.03% 370
2025
Q4
$317K Sell
4,011
-1,101
-22% -$87.1K 0.04% 327
2025
Q3
$421K Sell
5,112
-995
-16% -$78.3K 0.05% 288
2025
Q2
$491K Sell
6,107
-127
-2% -$9.8K 0.06% 254
2025
Q1
$500K Buy
6,234
+855
+16% +$71.1K 0.07% 229
2024
Q4
$440K Buy
+5,379
New +$448K 0.06% 243

Other funds holding MET

Novem Group's MET Position: Q2 2026 in Review

Novem Group reduced its MetLife (MET) stake by 14% in Q2 2026, selling an estimated $41.7K and leaving 3,297 shares worth $279K. The position accounts for 0.03% of the portfolio, ranked #368.

Novem Group first reported a position in MET in Q4 2024 and has held it in 7 quarters since. The position peaked at $500K in Q1 2025. 423 funds tracked by Wall St. Rank hold MET as of Q2 2026.

  • Novem Group held 3,297 shares of MetLife worth $279K as of Q2 2026.
  • Novem Group sold 517 MetLife shares in Q2 2026, an estimated $41.7K.
  • MetLife made up 0.03% of Novem Group's portfolio in Q2 2026, its #368 holding.
  • Novem Group first reported a position in MetLife in Q4 2024 and has held it in 7 quarters since.
  • Novem Group's MetLife position peaked at $500K in Q1 2025.
  • 423 funds tracked by Wall St. Rank held MetLife as of Q2 2026.

Based on Novem Group's 13F filing for Q2 2026, filed 21 Jul 2026.